Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Organ cell membranes are the lipid bilayer structures that encapsulate cells within organs, serving as critical barriers and functional interfaces for cellular processes. In the context of organ preservation and stabilization, these membranes are primary targets because they are highly susceptible to damage during storage, freezing, thawing, or perfusion procedures used in transplantation and biopreservation. Effective stabilization requires understanding both physical properties (fluidity/phase behavior) and biochemical vulnerabilities (oxidative damage). Ongoing research focuses on refining cryoprotectant use, developing advanced perfusion techniques/supplements, and engineering more resilient biomimetic systems based on natural membrane properties.
Membrane stabilization via cryoprotection, modulation of fluidity, and prevention of oxidative damage.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organ Cell Membranes.